Astrazeneca Plc ADR (AZN): Congress and insider trades

Who in Congress and inside the company traded AZN, when each filing appeared, and what buying after each one would have earned against the S&P 500.

Key Facts

  • Astrazeneca Plc ADR (AZN) is a listed stock on NASDAQ.
  • 11 members of Congress filed 17 buys and 17 sells of AZN, the latest published 2026-07-21 (21 July 2026).
  • Insiders filed 1 open market buy worth $3.2K and 0 sells worth $0, the latest filed 2026-09-11 (11 September 2026).
  • Across 10 scored buys, Congress averaged -3.0% against the S&P 500 (SPY) over the 90 days after disclosure, with 60% of them ahead of the index. That result is based on too few months of entries (9) to judge.
  • Data as of 2026-09-29 (29 September 2026).
Congress buys 17 11 members
Congress sells 17
Insider buys 1 $3.2K
Insider sells 0 $0
Congress buys vs S&P, 90d -3.0% 10 scored buys
Insider buys vs S&P, 90d n/a 0 scored buys

Congress trades in AZN

as of 2026-07-21
  1. Michael McCaul14 trades
  2. Ro Khanna7 trades
  3. Alan Lowenthal4 trades
  4. Alan Armstrong2 trades
  5. Gil Cisneros2 trades
  6. Daniel S. Goldman1 trade
  7. Sara Jacobs1 trade
  8. Bruce Westerman1 trade
Congress trades in AZN, newest first.
FiledMemberTypeSizeDays to file90 day vs S&P
21 Jul 2026 Alan Armstrong (R-OK) buy 1K–15K 112 n/a
21 Jul 2026 Alan Armstrong (R-OK) buy 15K–50K 113 n/a
9 Apr 2026 Ro Khanna (D-CA) buy 1K–15K 25 -23.4%
12 Mar 2026 Ro Khanna (D-CA) sell 15K–50K 24 n/a
14 Jan 2026 Julia Letlow (R-LA) buy 1K–15K 36 +6.8%
13 Jan 2026 Gil Cisneros (D-CA) buy 1K–15K 25 +6.3%
16 Dec 2025 Gil Cisneros (D-CA) buy 1K–15K 26 +7.3%
13 May 2025 Bruce Westerman (R-AR) sell 1K–15K 21 n/a
10 Nov 2023 Ro Khanna (D-CA) buy 1K–15K 26 -16.6%
25 Sep 2023 Michael McCaul (R-TX) sell 50K–100K 37 n/a
25 Sep 2023 Michael McCaul (R-TX) sell 100K–250K 37 n/a
7 Sep 2023 Ro Khanna (D-CA) buy 1K–15K 26 -10.1%
18 Aug 2023 Michael McCaul (R-TX) sell 15K–50K 41 n/a
18 Aug 2023 Michael McCaul (R-TX) sell 15K–50K 16 n/a
18 Aug 2023 Michael McCaul (R-TX) sell 15K–50K 16 n/a
18 Aug 2023 Michael McCaul (R-TX) sell 50K–100K 41 n/a
14 Aug 2023 Daniel S. Goldman (D-NY) sell 100K–250K 34 n/a
23 Jun 2023 Michael McCaul (R-TX) sell 15K–50K 51 n/a
23 Jun 2023 Michael McCaul (R-TX) sell 15K–50K 51 n/a
10 Mar 2023 Ro Khanna (D-CA) buy 15K–50K 26 +1.6%
21 Jan 2023 Michael McCaul (R-TX) sell 1K–15K 35 n/a
21 Jan 2023 Michael McCaul (R-TX) sell 1K–15K 35 n/a
15 Jun 2022 Michael McCaul (R-TX) buy 50K–100K 40 -10.9%
15 Jun 2022 Michael McCaul (R-TX) buy 50K–100K 40 -10.9%
27 May 2022 Michael McCaul (R-TX) buy 100K–250K 27 +1.8%
27 May 2022 Michael McCaul (R-TX) buy 100K–250K 27 +1.8%
10 Jan 2022 Ro Khanna (D-CA) sell 1K–15K 31 n/a
10 Jan 2022 Ro Khanna (D-CA) sell 1K–15K 24 n/a
15 Dec 2021 Alan Lowenthal (D-CA) sell 1K–15K 13 n/a
14 Aug 2021 Dean Phillips (D-MN) receive 1K–15K 23 n/a
29 May 2021 Sara Jacobs (D-CA) sell 15K–50K 49 n/a
6 Mar 2021 Alan Lowenthal (D-CA) buy < 1K 11 +6.8%
6 Mar 2021 Alan Lowenthal (D-CA) buy 15K–50K 11 +6.8%
6 Mar 2021 Alan Lowenthal (D-CA) buy 1K–15K 11 +6.8%
24 Dec 2020 Greg Gianforte (R-MT) buy 1K–15K 22 n/a

Insider trades in AZN

as of 2026-09-11
Open market insider trades in AZN, newest first.
FiledInsiderTypeSharesPriceValue90 day vs S&P
11 Sep 2026 Sharma Mani buy 20 $160.57 $3.2K n/a

Frequently asked questions

Who has bought AZN?

17 Congress buys by 11 members and 1 insider buy are on file. The tables on this page list every one.

Did buying AZN after a disclosure beat the market?

Across 10 scored buys, Congress averaged -3.0% against the S&P 500 (SPY) over the 90 days after disclosure, with 60% of them ahead of the index. That result is based on too few months of entries (9) to judge. A single stock is a small sample.

Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.

Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.